Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018066 · ClinicalTrials.gov registry record · NA
The Effect of Concord Grape Polyphenol-soy Protein Isolate Complex (GP-SPI) on Gut Microbiota
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04018066 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 34 participants.
The verdict
NCT04018066, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate the effect of nutritional supplementation with a well-characterized preparation of Concord grape polyphenol-soy protein isolate (GP-SPI) on the composition of the gut microbiota.
Interventions
- DIETARY_SUPPLEMENT GP-SPI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-06-28 |
| Est. Completion | 2019-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04018066
The ClinicalTrials.gov registry entry for NCT04018066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GP-SPI is the first listed.
NCT04018066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04018066 about?
NCT04018066 is a clinical study titled "The Effect of Concord Grape Polyphenol-soy Protein Isolate Complex (GP-SPI) on Gut Microbiota". The overall purpose of this study is to evaluate the effect of nutritional supplementation with a well-characterized preparation of Concord grape polyphenol-soy protein isolate (GP-SPI) on the composition of the gut microbiota.
What is the current status of trial NCT04018066?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-06-28. Estimated completion is 2019-12-20.
What interventions are being tested in trial NCT04018066?
The interventions under investigation include: GP-SPI (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04018066?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.